JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2002; 39:1175-1181
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hambrecht, R.
Right arrow Articles by Schuler, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hambrecht, R.
Right arrow Articles by Schuler, G.

CLINICAL STUDY: HEART FAILURE

Reduction of insulin-like growth factor-I expression in the skeletal muscle of noncachectic patients with chronic heart failure

Rainer Hambrecht, MD*,*, Paul Christian Schulze, MD*, Stephan Gielen, MD*, Axel Linke, MD*, Sven Möbius-Winkler, MD*, Jiangtao Yu, MD*, J.ürgen Kratzsch, MD§, Gerhard Baldauf, MD{ddagger}, Martin W. Busse, MD||, Andreas Schubert, PhD{dagger}, Volker Adams, PhD* and Gerhard Schuler, MD*

* University of Leipzig–Heart Center, Department of Cardiology; Leipzig, Germany
{dagger} Department of Cardiac Surgery, University of Leipzig–Heart Center, Leipzig, Germany
{ddagger} Department of Radiology, University of Leipzig–Heart Center, Leipzig, Germany
§ Institute of Clinical Chemistry, Leipzig, Germany
|| Institute of Sport Medicine, Leipzig, Germany

Manuscript received September 17, 2001; revised manuscript received December 28, 2001, accepted January 11, 2002.

* Reprint requests and correspondence: Dr. Rainer Hambrecht, Professor of Medicine, Heart Center, University of Leipzig, Strümpellstr. 39, 04289 Leipzig, Germany.
hamr{at}medizin.uni-leipzig.de

OBJECTIVES: We sought to assess the role of insulin-like growth factor-I (IGF-I) in muscle wasting in chronic heart failure (CHF), serum concentrations and local muscular IGF-I expression were determined in patients with severe CHF.

BACKGROUND: Chronic heart failure is associated with progressive muscle atrophy, leading to cardiac cachexia. Skeletal muscle disuse and inflammatory activation with elevated cytokine levels have been implicated; however, the pathomechanism involved remains largely unknown.

METHODS: Serum levels of IGF-I were measured by competitive solid phase immunoassay in 47 patients with severe CHF (left ventricular ejection fraction ≤30%) and 15 age-matched healthy subjects (HS). Insulin-like growth factor-I and IGF-I receptor expression were assessed in vastus lateralis biopsies by real-time PCR and Western blot analysis.

RESULTS: Although serum IGF-I was not significantly different (175 ± 10 ng/ml in CHF vs. 170 ± 12 ng/ml in HS, p = NS), local muscle IGF-I mRNA expression was reduced by 52% in CHF (6.7 ± 0.4 vs. 14.0 ± 0.9 arbitrary units in HS, p < 0.001). This was accompanied by an increase in IGF-I receptor mRNA expression (86.8 ± 5.4 in CHF vs. 23.1 ± 1.8 arbitrary units in HS, p < 0.001). Local IGF-I expression was significantly correlated with muscle cross-sectional area (R = 0.75, p = 0.01). Chronic heart failure patients with a body mass index of <25 kg/m2 showed signs of peripheral growth hormone (GH) resistance, as indicated by elevated serum GH, and reduced IGF-I levels.

CONCLUSIONS: In CHF patients, muscle IGF-I expression is considerably reduced in the presence of normal serum IGF-I levels, possibly contributing to early loss of muscle mass. These findings are consistent with a potential role of IGF-I for skeletal muscle atrophy in CHF.

Abbreviations and Acronyms
  CHF
  chronic heart failure
  CMP
  cardiomyopathy
  DCM
  dilated cardiomyopathy
  GH
  growth hormone
  HS
  healthy subjects
  IGF-I
  insulin-like growth factor-I
  IGFBP-3
  insulin-like growth factor binding protein-3
  IHD
  ischemic heart disease
  LVEF
  left ventricular ejection fraction
  mRNA
  messenger ribonucleic acid
  TNF-{alpha}
  tumor necrosis factor-{alpha}
  VO2max
  maximal oxygen uptake




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
T. H. Le Jemtel, M. Padeletti, and S. Jelic
Diagnostic and Therapeutic Challenges in Patients With Coexistent Chronic Obstructive Pulmonary Disease and Chronic Heart Failure
J. Am. Coll. Cardiol., January 16, 2007; 49(2): 171 - 180.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. Costelli, M. Muscaritoli, M. Bossola, F. Penna, P. Reffo, A. Bonetto, S. Busquets, G. Bonelli, F. J. Lopez-Soriano, G. B. Doglietto, et al.
IGF-1 is downregulated in experimental cancer cachexia
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R674 - R683.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. J. Toth, P. A. Ades, M. M. LeWinter, R. P. Tracy, and A. Tchernof
Skeletal muscle myofibrillar mRNA expression in heart failure: relationship to local and circulating hormones
J Appl Physiol, January 1, 2006; 100(1): 35 - 41.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. C. Schulze, J. Fang, K. A. Kassik, J. Gannon, M. Cupesi, C. MacGillivray, R. T. Lee, and N. Rosenthal
Transgenic Overexpression of Locally Acting Insulin-Like Growth Factor-1 Inhibits Ubiquitin-Mediated Muscle Atrophy in Chronic Left-Ventricular Dysfunction
Circ. Res., September 2, 2005; 97(5): 418 - 426.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
V. Adams, A. Linke, N. Krankel, S. Erbs, S. Gielen, S. Mobius-Winkler, J. F. Gummert, F. W. Mohr, G. Schuler, and R. Hambrecht
Impact of Regular Physical Activity on the NAD(P)H Oxidase and Angiotensin Receptor System in Patients With Coronary Artery Disease
Circulation, February 8, 2005; 111(5): 555 - 562.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. P. Curtis, J. G. Selter, Y. Wang, S. S. Rathore, I. S. Jovin, F. Jadbabaie, M. Kosiborod, E. L. Portnay, S. I. Sokol, F. Bader, et al.
The Obesity Paradox: Body Mass Index and Outcomes in Patients With Heart Failure
Arch Intern Med, January 10, 2005; 165(1): 55 - 61.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
M A Spruit, M J Thomeer, R Gosselink, T Troosters, A Kasran, A J T Debrock, M G Demedts, and M Decramer
Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status
Thorax, January 1, 2005; 60(1): 32 - 38.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
L. Dalla Libera, B. Ravara, M. Volterrani, V. Gobbo, M. Della Barbera, A. Angelini, D. D. Betto, E. Germinario, and G. Vescovo
Beneficial effects of GH/IGF-1 on skeletal muscle atrophy and function in experimental heart failure
Am J Physiol Cell Physiol, January 1, 2004; 286(1): C138 - C144.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
M A Spruit, R Gosselink, T Troosters, A Kasran, G Gayan-Ramirez, P Bogaerts, R Bouillon, and M Decramer
Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I
Thorax, September 1, 2003; 58(9): 752 - 756.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Hambrecht, V. Adams, S. Erbs, A. Linke, N. Krankel, Y. Shu, Y. Baither, S. Gielen, H. Thiele, J.F. Gummert, et al.
Regular Physical Activity Improves Endothelial Function in Patients With Coronary Artery Disease by Increasing Phosphorylation of Endothelial Nitric Oxide Synthase
Circulation, July 1, 2003; 107(25): 3152 - 3158.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2002 by the American College of Cardiology Foundation.